Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 69,300
+800 (1.17%)
Jul 21, 2026, 2:35 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 446.45 billion as of July 20, 2026. Its market cap has decreased by -60.98% in one year.
Market Cap
446.45B
Enterprise Value
534.28B
Revenue
244.02B
Ranking
n/a
PE Ratio
20.94
Stock Price
69,300.00
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 446.45B, an increase of 522.45%. That is a compound annual growth rate of 11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 446.45B | -47.35% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 986.07B |
| Chabiotech | 843.62B |
| Pharmicell | 665.30B |
| Onconic Therapeutics | 658.41B |
| GI Innovation | 472.26B |
| GC Corp. | 437.22B |
| MEDIPOST | 342.39B |
| Genomictree | 289.66B |